Search results
Five Below, Inc. Announces First Quarter Fiscal 2024 Financial Results - Five Below (NASDAQ:FIVE)
Benzinga· 2 days agoQ1 Net Sales Increase of 11.8% to $811.9 million GAAP Diluted EPS of $0.57; Adjusted Diluted EPS of $0.60 Updates Full Year 2024 Guidance PHILADELPHIA, PA, June 05, 2024 (GLOBE NEWSWIRE) -- Five Below, Inc.
Arras Minerals Closes C$5.2 Million Non-Brokered Financing
Digital Journal· 19 hours agoVANCOUVER, BC / ACCESSWIRE / June 6, 2024 / Arras Minerals Corp. (TSXV:ARK) ("Arras" or the "Company") is pleased to announce that further to its news release dated May 29, 2024, it has closed ...
SolGold PLC Announces Exploitation Contract for Cascabel Project
Morningstar· 1 day agoBISHOPSGATE, LONDON / ACCESSWIRE / June 6, 2024 / SolGold (LSE:SOLG)(TSX:SOLG) is pleased to announce the signing of the Exploitation Contract ("Exploitation Contract" or "EC") for the Cascabel ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoSunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations PR Newswire SHANGHAI, June 2, 2024 The global pivotal WU-KONG1B study investigating sunvozertinib achieved
Xebra Brands Congratulates President Elect Claudia Sheinbaum on Historic Victory as Mexico's First...
Digital Journal· 3 days agoKnown and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements. Such factors include...
AirIQ Expands Reach with Strategic Partnership with Teltonika
Digital Journal· 3 days agoThese forward-looking statements are related to, but not limited to, AirIQ's operations, anticipated financial performance, business...and unknown risks, uncertainties and ...
NUBURU Expands Japanese Market Presence With JLC Installation of BL250 BlueScan System In Osaka
PhotonicsOnline· 3 days agoCentennial, CO - (BUSINESS WIRE) - NUBURU, Inc. (“NUBURU” or the “Company”) (NYSE American: BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, today ...
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Morningstar· 6 days agoSummit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) announced that the Journal of the American Medical Association (JAMA) published a manuscript titled, “Ivonescimab Plus ...
Innovent Delivers Oral Presentation of Clinical Data of A Randomized Controlled Phase 1b Study...
KOIN News 6 Portland· 5 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 3 days agoPharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks, recently ...
